11.12.2012 Views

NASA Scientific and Technical Aerospace Reports

NASA Scientific and Technical Aerospace Reports

NASA Scientific and Technical Aerospace Reports

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

20040111604 Winston-Salem State Univ., Winston-Salem, NC<br />

A Novel Apoptosis Pathway that is Defective in Early Breast Cancer<br />

Thorburn, Andrew M.; Phil, D.; Apr. 2004; 9 pp.; In English<br />

Contract(s)/Grant(s): DAMD17-02-1-0612<br />

Report No.(s): AD-A425681; No Copyright; Avail: CASI; A02, Hardcopy<br />

This project studies a novel apoptosis pathway that is induced by the death domain of the adaptor protein FADD<br />

(FADD-DD) . This pathway can induce apoptosis only in normal epithelial cells from the breast (or prostate) <strong>and</strong> its<br />

inactivation may represent an early defect that arises in breast cancer. SV4O T antigen can selectively block this apoptosis<br />

pathway. The overall goal of this project is to investigate <strong>and</strong> further underst<strong>and</strong> why breast cancer cells are resistant to this<br />

apoptosis pathway. As outlined in the previous progress report, we achieved all the goals for aim 1 <strong>and</strong> made new observations<br />

that allow alternate approaches to address the project. Importantly we showed that mouse breast epithelial cells display the<br />

same apoptosis response to FADD- DD. The reviewer of our previous progress report suggested that we study this response<br />

in the absence of Sv4OT antigen since this would be more applicable to actual breast cancer. We therefore continued with our<br />

studies as outlined in the statement of work <strong>and</strong> exp<strong>and</strong>ed our studies in mouse cells that allow us to avoid the use of Sv4O<br />

T antigen. Our data show that inactivation of the p53, Rb, INK4a/ARF pathways do not explain resistance to this apoptosis.<br />

DTIC<br />

Apoptosis; Cancer; Defects; Mammary Gl<strong>and</strong>s<br />

20040111605<br />

Distribution of the Coenzyme M Pathway of Epoxide Metabolism Among Ethene-<strong>and</strong> Vinyl Chloride-Degrading<br />

Mycobacterium Strains<br />

Coleman, Nicholas V.; Spain, Jim C.; Jul. 9, 2003; 7 pp.; In English<br />

Report No.(s): AD-A425682; No Copyright; Avail: CASI; A02, Hardcopy<br />

An epoxyalkane:coenzyme M (CoM) transferase (EaCoMT) enzyme was recently found to be active in the aerobic vinyl<br />

chloride (VC) <strong>and</strong> ethene assimilation pathways of Mycobacterium strain JS6O. In the present study, EaCoMT activity <strong>and</strong><br />

genes were investigated in 10 different mycobacteria isolated on VC or ethene from diverse environmental samples. In all<br />

cases, epoxyethane metabolism in cell extracts was dependent on CoM, with average specific activities of EaCoMT between<br />

380 <strong>and</strong> 2,910 nmol/min/ mg of protein, PCR with primers based on conserved regions of EaCoMT genes from<br />

Mycobacterium strain JS6O <strong>and</strong> the propene oxidizers Xanthobacter strain Py2 <strong>and</strong> Rhodococcus strain B-276 yielded<br />

fragments (834 bp) of EaCoMT genes from all of the VC- <strong>and</strong> ethne-assimilating isolates. The Mycobacterium EaCoMT genes<br />

form a distinct cluster <strong>and</strong> are more closely related to the EaCoMT of Rhodococcus strain B%276 than that of Xanthobacter<br />

strain ....... The CoM-mediated pathway of epoxide metabolism appears to be universal in alkene-assimilating mycobacteria,<br />

possibly because of plasmid-mediated lateral gene transfer.<br />

DTIC<br />

Chlorides; Coenzymes; Degradation; Enzymes; Epoxy Compounds; Metabolism; Vinyl Radical<br />

20040111606 Fox Chase Cancer Center, Philadelphia, PA<br />

Cloning of a New Gene/s in Chromosome 17p3.2-p13.1 that Control Apoptosis<br />

Russo, Jose; Apr. 2004; 20 pp.; In English; Original contains color illustrations<br />

Contract(s)/Grant(s): DAMD17-02-1-0384<br />

Report No.(s): AD-A425683; No Copyright; Avail: CASI; A03, Hardcopy<br />

Loss of genetic material (LOH) in the chromosome 17 p13 .2 at the microsatellite marker Dl7S796 has been identified<br />

in atypical ductal hyperplasia <strong>and</strong> in situ ductal carcinoma of the breast. Our results shown LOH at the same region in<br />

MCF-lOF cells treated with the chemical carcinogen benz(a)pyrene (BP). Moreover, microcell-mediated transfer of an intact<br />

copy of human chromosome 17 inhibited the tumorigenicity of BPlE <strong>and</strong> PCR-SSCP analyzes showed a restoration of the lost<br />

material in BPlE-17-neo. These experiments suggested the presence of a tumor suppressor gene in 17pl3 .2 near the marker<br />

Dl 7S796. We have been able to clone a fragment of the genes that could represent the last exon of a bigger peptide. The<br />

presence of a 3’ splicing site in the putative introns <strong>and</strong> the ATTAAA region at the 3’end support this idea. The predicted amino<br />

acid sequence does not share significant homology with any known protein supporting the idea that this could be a novel<br />

protein. Further experiments will be done in order to clone the full-Length cDNA <strong>and</strong> to study the regulation of the expression<br />

of this novel gene.<br />

DTIC<br />

Apoptosis; Cancer; Chromosomes; Cloning (Biology); Genes; Mammary Gl<strong>and</strong>s<br />

185

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!